NCT02257723 The Effect of Integrated CAM Treatment in Hospitalized Patients
| NCT ID | NCT02257723 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jaseng Hospital of Korean Medicine |
| Condition | Low Back Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2012-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2012-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the effect of hospital-based intensive non-surgical treatment in musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized due to spine or joint diseases Exclusion Criteria: * Main complaint other than back pain, radiating leg pain, neck pain, radiating arm pain, knee pain or shoulder pain * Cause of pain non-related to spine, joint or soft tissue; for example, spinal tumors, pregnancy, urolithiasis, etc. * Refusal to provide the information needed for clinical research
Contact & Investigator
In-Hyuk Ha, PhD
PRINCIPAL INVESTIGATOR
Jaseng Medical Foundation
Frequently Asked Questions
Who can join the NCT02257723 clinical trial?
This trial is open to participants of all sexes, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02257723 currently recruiting?
Yes, NCT02257723 is actively recruiting participants. Contact the research team at hanihata@gmail.com for enrollment information.
Where is the NCT02257723 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT02257723 clinical trial?
NCT02257723 is sponsored by Jaseng Hospital of Korean Medicine. The principal investigator is In-Hyuk Ha, PhD at Jaseng Medical Foundation. The trial plans to enroll 100,000 participants.